Moderna’s mRNA Flu Shot Gets FDA Approval | Chattanooga News

The FDA just approved Moderna’s groundbreaking mRNA flu vaccine, mFLUSIVA — the first of its kind — for adults 50 and older, offering faster production and potentially better protection than traditional shots. While initial trials showed strong results, questions linger about its comparison to older vaccines, prompting Moderna to commit to further studies. Side effects are mild — sore arm, fatigue — but the promise is huge: a faster, more adaptable flu defense that could reshape public health for years to come. Listen in comfort:Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn. Advertise on DNN:[email protected] This is an automated, high-level news summary based on public reporting.Report issues to [email protected]. View sources & latest updates:https://sources.thednn.ai/664461e126ad732d